J. Safra Sarasin Holding’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$683K Sell
8,567
-8,325
-49% -$672K 0.01% 474
2026
Q1
$1.46M Sell
16,892
-23,557
-58% -$2.26M 0.02% 240
2025
Q4
$3.89M Buy
40,449
+1,593
+4% +$155K 0.06% 145
2025
Q3
$3.69M Buy
38,856
+7,543
+24% +$693K 0.06% 156
2025
Q2
$2.72M Sell
31,313
-141,012
-82% -$12M 0.05% 176
2025
Q1
$15.5M Sell
172,325
-3,690
-2% -$330K 0.28% 89
2024
Q4
$14.1M Sell
176,015
-17,368
-9% -$1.5M 0.24% 99
2024
Q3
$17.4M Buy
193,383
+116,948
+153% +$9.84M 0.3% 84
2024
Q2
$6.02M Buy
+76,435
New +$6.27M 0.11% 128

Other funds holding MDT

J. Safra Sarasin Holding's MDT Position: Q2 2026 in Review

J. Safra Sarasin Holding reduced its Medtronic (MDT) stake by 49% in Q2 2026, selling an estimated $672K and leaving 8,567 shares worth $683K. The position accounts for 0.01% of the portfolio, ranked #474.

J. Safra Sarasin Holding first reported a position in MDT in Q2 2024 and has held it in 9 quarters since. The position peaked at $17.4M in Q3 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • J. Safra Sarasin Holding held 8,567 shares of Medtronic worth $683K as of Q2 2026.
  • J. Safra Sarasin Holding sold 8,325 Medtronic shares in Q2 2026, an estimated $672K.
  • Medtronic made up 0.01% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #474 holding.
  • J. Safra Sarasin Holding first reported a position in Medtronic in Q2 2024 and has held it in 9 quarters since.
  • J. Safra Sarasin Holding's Medtronic position peaked at $17.4M in Q3 2024.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.